The Journal of urology
Primary Retroperitoneal Lymph Node Dissection in Marker Positive Clinical Stage II Non-Seminomatous Germ Cell Tumours.
Ahmad Mousa, Julian Chavarriaga, Sanchit Kaushal, Zacharia Burrafato, Lynn Anson-Cartwright, Eshetu G Atenafu, Philippe Bedard, Di Maria Jiang, Rachel Glicksman, Peter Chung, Padraig Warde, Martin O'Malley, Susan Prendeville, Michael A S Jewett, Robert J Hamilton
Published: 202510.1097/JU.0000000000004847
Abstract
PURPOSE: Guidelines usually recommend chemotherapy rather than primary retroperitoneal lymph node dissection (pRPLND) for clinical stage II non-seminomatous germ cell tumours (NSGCTs) with elevated serum tumour markers (STMs). This study evaluated on…
Preview only. Read the full abstract at the source